BEHIND THE SCIENCE
Focused on providing actionable insights to clinicians.

MediBeacon’s use of proprietary fluorescent tracer agents coupled with transdermal detection technology focuses on providing vital and actionable measurement of organ function.

The Company’s Transdermal GFR Measurement System (TGFR) is designed to be a direct measure of Glomerular Filtration Rate (GFR) at the point of care. This system employs a fluorescent tracer agent which has been engineered to be excreted exclusively by the kidneys. Noninvasive transdermal fluorescence detection of the excretion rate of the agent is converted into measured GFR by this system.

LIMITLESS POSSIBILITIES
Shining new light on physiological measurement.
PRODUCT PIPELINE
An extensive portfolio of light-activated agents.

Fluorescence and optical sensor-based systems are being optimized to provide physiological function monitoring at the inpatient and outpatient point of care.

88%
of doctors would like their patients to monitor their health at home, particularly their weight, blood sugar, and vital signs.
- PricewaterhouseCoopers, Health Research Institute Physician Survey, 2010